Blog

American Association for Cancer Research Conference on Optimizing Therapeutic Efficacy and Tolerability through Cancer Chemistry

www.aacr.org

Oct 28, 2024, 09:45

American Association for Cancer Research Conference on Optimizing Therapeutic Efficacy and Tolerability through Cancer Chemistry

American Association for Cancer Research shared a post on LinkedIn:

“Register by October 28 to get the lowest rates for the AACR Conference on Optimizing Therapeutic Efficacy and Tolerability through Cancer Chemistry (December 9-11, Toronto), chaired by Philip Jones, Angela N. Koehler, and Chudi Ndubaku and organized in association with the AACR Chemistry in Cancer Research Working Group.

Learn more.”

AACR AACR Conference American Association for Cancer Research Angela N. Koehler cancer cancer awareness cancer care Chudi Ndubaku fight against cancer Global fight against cancer OncoDaily Oncology Philip Jones

Dr. Manette Le Grange joins OncoDaily Editorial Board

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

New Paper Alert Real-Life Impact of Enfortumab Vedotin or Chemotherapy in the Sequential Treatment of Advanced Urothelial Carcinoma: The ARON-2 Retrospective Experience

Highlights from TTLC2025

KIMMTRAK (Tebentafusp) uses in Cancer: Dosages, Indications, Expectations and more